estrone has been researched along with Thrombosis in 9 studies
Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.
Thrombosis: Formation and development of a thrombus or blood clot in the blood vessel.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report two cases of stroke associated with the use of finasteride at 1 mg/day, which is approved in Japan for the treatment of male-pattern hair loss." | 7.80 | [Two cases of stroke associated with the use of finasteride, an approved drug for male-pattern hair loss in Japan]. ( Bono, K; Imafuku, I; Kitamura, M; Nakayama, T; Tsuji, Y, 2014) |
| "We report two cases of stroke associated with the use of finasteride at 1 mg/day, which is approved in Japan for the treatment of male-pattern hair loss." | 3.80 | [Two cases of stroke associated with the use of finasteride, an approved drug for male-pattern hair loss in Japan]. ( Bono, K; Imafuku, I; Kitamura, M; Nakayama, T; Tsuji, Y, 2014) |
| "Estrone levels were inversely associated with the natural anticoagulant, protein S antigen." | 1.46 | Cross-sectional association of endogenous steroid hormone, sex hormone-binding globulin, and precursor steroid levels with hemostatic factor levels in postmenopausal women. ( Blondon, M; Harrington, LB; Heckbert, SR; LaCroix, AZ; Marck, BT; Matsumoto, AM; McKnight, B; Psaty, BM; Rosendaal, FR; Smith, NL; Wiggins, KL; Woods, NF, 2017) |
| " Requisites of such therapy are a through history to establish a real need, a complete gynecologic examination with a Pap smear before therapy begins and annually afterward, use of the smallest daily dose of estrogen that gives the desired effect, and periodic attempts to reduce the dosage or stop the hormone." | 1.26 | Estrogens for the menopause. Maximizing benefits, minimizing risks. ( Seller, JC, 1977) |
| " The dosage of the drug was 750 mg." | 1.25 | Prostatic cancer and SCH-13521: II. Histological alterations and the pituitary gonadal axis. ( Daly, JJ; Griffin, PP; Irwin, RJ; Kliman, B; MacLaughlin, RA; Prout, GR, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Medved, L | 1 |
| Weisel, JW | 1 |
| Yang, HR | 1 |
| Hwang, DH | 1 |
| Prakash, RLM | 1 |
| Kim, JH | 1 |
| Hong, IH | 1 |
| Kim, S | 1 |
| Kim, E | 1 |
| Kang, C | 1 |
| Tsuji, Y | 1 |
| Nakayama, T | 1 |
| Bono, K | 1 |
| Kitamura, M | 1 |
| Imafuku, I | 1 |
| Harrington, LB | 1 |
| Marck, BT | 1 |
| Wiggins, KL | 1 |
| McKnight, B | 1 |
| Heckbert, SR | 1 |
| Woods, NF | 1 |
| LaCroix, AZ | 1 |
| Blondon, M | 1 |
| Psaty, BM | 1 |
| Rosendaal, FR | 1 |
| Matsumoto, AM | 1 |
| Smith, NL | 1 |
| Swanepoel, AC | 1 |
| Naidoo, P | 1 |
| Nielsen, VG | 1 |
| Pretorius, E | 1 |
| Bagot, CN | 1 |
| Marsh, MS | 1 |
| Whitehead, M | 1 |
| Sherwood, R | 1 |
| Roberts, L | 1 |
| Patel, RK | 1 |
| Arya, R | 1 |
| Seller, JC | 1 |
| Prout, GR | 1 |
| Irwin, RJ | 1 |
| Kliman, B | 1 |
| Daly, JJ | 1 |
| MacLaughlin, RA | 1 |
| Griffin, PP | 1 |
| Wilson, JL | 1 |
| Ashburn, AD | 1 |
| Williams, WL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effectiveness and Safety of Different Estradiol Replacement Therapies in Transgender Female[NCT05010707] | Phase 2 | 100 participants (Anticipated) | Interventional | 2021-08-02 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for estrone and Thrombosis
| Article | Year |
|---|---|
The Story of the Fibrin(ogen) αC-Domains: Evolution of Our View on Their Structure and Interactions.
Topics: Estrone; Fibrin; Fibrinogen; Humans; Peptide Fragments; Polymers; Protein Structure, Tertiary; Throm | 2022 |
8 other studies available for estrone and Thrombosis
| Article | Year |
|---|---|
Exploring the Fibrin(ogen)olytic, Anticoagulant, and Antithrombotic Activities of Natural Cysteine Protease (Ficin) with the κ-Carrageenan-Induced Rat Tail Thrombosis Model.
Topics: Animals; Anticoagulants; Carrageenan; Cysteine Proteases; Estrone; Fibrin; Fibrinogen; Fibrinolytic | 2022 |
[Two cases of stroke associated with the use of finasteride, an approved drug for male-pattern hair loss in Japan].
Topics: 5-alpha Reductase Inhibitors; Administration, Oral; Adult; Alopecia; Anticoagulants; Diffusion Magne | 2014 |
Cross-sectional association of endogenous steroid hormone, sex hormone-binding globulin, and precursor steroid levels with hemostatic factor levels in postmenopausal women.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Androstenedione; Antithrombins; Cross-Sectional Studies; | 2017 |
Clinical relevance of hypercoagulability and possible hypofibrinolysis associated with estrone and estriol.
Topics: Adolescent; Adult; Estriol; Estrone; Female; Fibrin; Fibrinolysis; Humans; Male; Menopause; Pregnanc | 2017 |
The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy.
Topics: Administration, Cutaneous; Administration, Oral; Case-Control Studies; Estradiol; Estrogen Replaceme | 2010 |
Estrogens for the menopause. Maximizing benefits, minimizing risks.
Topics: Affective Symptoms; Arteriosclerosis; Breast Neoplasms; Climacteric; Cystitis; Estradiol; Estrogens; | 1977 |
Prostatic cancer and SCH-13521: II. Histological alterations and the pituitary gonadal axis.
Topics: Aged; Anilides; Biopsy, Needle; Cerebrovascular Disorders; Estradiol; Estrone; Flutamide; Follicle S | 1975 |
Effects of sex hormones on diet-induced atrial thrombosis.
Topics: Animals; Body Weight; Cardiovascular Diseases; Cardiovascular System; Caseins; Castration; Coronary | 1970 |